Guangzhou Kingmed Diagnostics Group Co., Ltd.

SHSE:603882 Voorraadrapport

Marktkapitalisatie: CN¥14.7b

Guangzhou Kingmed Diagnostics Group Beheer

Beheer criteriumcontroles 1/4

Momenteel beschikken wij niet over voldoende informatie over de CEO.

Belangrijke informatie

Yaoming Liang

Algemeen directeur

CN¥4.5m

Totale compensatie

Percentage CEO-salarisn/a
Dienstverband CEOno data
Eigendom CEO16.0%
Management gemiddelde ambtstermijngeen gegevens
Gemiddelde ambtstermijn bestuurless than a year

Recente managementupdates

Recent updates

Guangzhou Kingmed Diagnostics Group's (SHSE:603882) Weak Earnings May Only Reveal A Part Of The Whole Picture

Nov 06
Guangzhou Kingmed Diagnostics Group's (SHSE:603882) Weak Earnings May Only Reveal A Part Of The Whole Picture

Earnings Tell The Story For Guangzhou Kingmed Diagnostics Group Co., Ltd. (SHSE:603882)

Sep 27
Earnings Tell The Story For Guangzhou Kingmed Diagnostics Group Co., Ltd. (SHSE:603882)

Guangzhou Kingmed Diagnostics Group Co., Ltd. Just Missed Revenue By 9.5%: Here's What Analysts Think Will Happen Next

Sep 03
Guangzhou Kingmed Diagnostics Group Co., Ltd. Just Missed Revenue By 9.5%: Here's What Analysts Think Will Happen Next

Is Guangzhou Kingmed Diagnostics Group (SHSE:603882) Using Too Much Debt?

Aug 25
Is Guangzhou Kingmed Diagnostics Group (SHSE:603882) Using Too Much Debt?

A Look At The Fair Value Of Guangzhou Kingmed Diagnostics Group Co., Ltd. (SHSE:603882)

Jun 04
A Look At The Fair Value Of Guangzhou Kingmed Diagnostics Group Co., Ltd. (SHSE:603882)

Guangzhou Kingmed Diagnostics Group's (SHSE:603882) Shareholders Have More To Worry About Than Only Soft Earnings

May 02
Guangzhou Kingmed Diagnostics Group's (SHSE:603882) Shareholders Have More To Worry About Than Only Soft Earnings

Investors Don't See Light At End Of Guangzhou Kingmed Diagnostics Group Co., Ltd.'s (SHSE:603882) Tunnel And Push Stock Down 26%

Apr 17
Investors Don't See Light At End Of Guangzhou Kingmed Diagnostics Group Co., Ltd.'s (SHSE:603882) Tunnel And Push Stock Down 26%

Investor Optimism Abounds Guangzhou Kingmed Diagnostics Group Co., Ltd. (SHSE:603882) But Growth Is Lacking

Feb 28
Investor Optimism Abounds Guangzhou Kingmed Diagnostics Group Co., Ltd. (SHSE:603882) But Growth Is Lacking

CEO

Yaoming Liang (60 yo)

no data

Tenure

CN¥4,503,500

Compensatie

Mr. Yaoming Liang serves as the Chairman of the Board and General Manager of Guangzhou Kingmed Diagnostics Group Co., Ltd. (formerly known as Guangzhou KingMed Center for Clinical Laboratory Co., Ltd) and...


Bestuursleden

NaamPositieTenureCompensatieEigendom
Yaoming Liang
Chairman & GMno dataCN¥4.50m15.96%
CN¥ 2.3b
Bixi Hao
Deputy GMno dataCN¥2.62m0.011%
CN¥ 1.7m
Linglai Wang
Deputy GM4.8yrsCN¥1.67m0.13%
CN¥ 19.5m
Ting Yan
Deputy GM & Directorno dataCN¥2.29m0.75%
CN¥ 110.7m
Huobao Xie
Independent Directorless than a yeargeen gegevensgeen gegevens
Zhanwen Zeng
Directorno dataCN¥1.04m0.75%
CN¥ 110.7m
Qiang Xie
Directorno datageen gegevensgeen gegevens
Jianhua Ling
Independent Directorno dataCN¥264.00kgeen gegevens
Yongjian Chen
Chairman of the Supervisory Boardno datageen gegevensgeen gegevens
Li Qin Zhou
Supervisorno datageen gegevensgeen gegevens
Xiaofeng Zou
Employee Representative Supervisorno datageen gegevensgeen gegevens
Xia Fan
Independent Directorless than a yeargeen gegevensgeen gegevens

0.8yrs

Gemiddelde duur

54.5yo

Gemiddelde leeftijd

Ervaren bestuur: De raad van bestuur van 603882 wordt niet als ervaren beschouwd (gemiddelde ambtstermijn 0.8 jaar), wat duidt op een nieuw bestuur.